Welcome to the sixth issue of our EU Life Sciences Review, which covers some of the most critical developments in the pharmaceutical and medical technology sectors in the last quarter and is produced by our life sciences lawyers in London, Frankfurt, Paris, and Moscow.
In this issue, we cover updates relating to:
Read the sixth issue of the
European Life Sciences Review >>